Skip to main content

Table 3 Summary of initial PSA (iPSA) levels by various patient characteristics in the overall cohort (n = 379)

From: Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes

Patient characteristic iPSA ng/ml (quartiles) p-value
25th-percentile Median 75th-percentile  
Age, Y     0.099
<65 13.3 32.9 100.0  
≥65 19.9 44.8 100.0  
Gleason Score     < 0.001
≤7 13.9 27.9 72.8  
8 to 10 34.6 68.3 268.2  
Clinical T stage     < 0.001
T1 - T2 9.4 19.8 39.0  
T3 - T4 22.7 50.4 90.1